Published in Biosecur Bioterror on December 01, 2008
Public willingness to take a vaccine or drug under Emergency Use Authorization during the 2009 H1N1 pandemic. Biosecur Bioterror (2009) 1.53
The social ecological model as a framework for determinants of 2009 H1N1 influenza vaccine uptake in the United States. Health Educ Behav (2011) 0.97
Predicting response to reassurances and uncertainties in bioterrorism communications for urban populations in New York and California. Biosecur Bioterror (2012) 0.82
Public response to an anthrax attack: a multiethnic perspective. Biosecur Bioterror (2012) 0.77
Health concerns in UK Armed Forces personnel. J R Soc Med (2009) 0.75
Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA (2004) 7.97
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med (2001) 5.23
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
The determinants of trust and credibility in environmental risk communication: an empirical study. Risk Anal (1997) 2.77
Risk communication, the West Nile virus epidemic, and bioterrorism: responding to the communication challenges posed by the intentional or unintentional release of a pathogen in an urban setting. J Urban Health (2001) 2.51
The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication? Vaccine (2006) 1.74
Interim guidelines for investigation of and response to Bacillus anthracis exposures. MMWR Morb Mortal Wkly Rep (2001) 1.70
Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis (2002) 1.68
Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis (2002) 1.59
Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis (2002) 1.51
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program. Pharmacoepidemiol Drug Saf (2005) 1.50
Communication of risk: choice, consent, and trust. Lancet (2002) 1.47
Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis (2002) 1.34
Best practices in public health risk and crisis communication. J Health Commun (2003) 1.25
Postal workers' perspectives on communication during the anthrax attack. Biosecur Bioterror (2005) 1.22
Leading during bioattacks and epidemics with the public's trust and help. Biosecur Bioterror (2004) 1.20
Anthrax 2001: observations on the medical and public health response. Biosecur Bioterror (2003) 1.17
Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis (2004) 1.17
Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis (2006) 1.16
In their own words: lessons learned from those exposed to anthrax. Am J Public Health (2005) 1.12
Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States. Emerg Infect Dis (2007) 1.12
Crisis and emergency risk communication in a pandemic: a model for building capacity and resilience of minority communities. Health Promot Pract (2008) 1.10
Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep (2002) 1.00
Communicating in times of uncertainty: the need for trust. J Health Commun (2003) 0.92
Concerns of Capitol Hill staff workers after bioterrorism: focus group discussions of authorities' response. J Nerv Ment Dis (2005) 0.91
Vaccine risk communication. Am J Prev Med (1998) 0.89
A bitter pill to swallow: nonadherence with prophylactic antibiotics during the anthrax attacks and the role of private physicians. Biosecur Bioterror (2004) 0.89
Smallpox vaccination: a national survey of emergency health care providers. Acad Emerg Med (2003) 0.87
Emergency physicians' perspectives on smallpox vaccination. Acad Emerg Med (2003) 0.86
Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program. Pharmacoepidemiol Drug Saf (2006) 0.86
Adult tetanus, diphtheria and pertussis immunization: knowledge, beliefs, behavior and anticipated uptake. Vaccine (2004) 0.85
Reasons physicians accepted or declined smallpox vaccine, February through April, 2003. J Gen Intern Med (2004) 0.85
Vaccination and risk communication: summary of a workshop, Arlington Virginia, USA, 5-6 October 2000. J Paediatr Child Health (2002) 0.84
Risk communication and terrorism. Biosecur Bioterror (2004) 0.83
Communicating risk: from crisis to calm. J Health Commun (2005) 0.82
The Institute of Medicine's independent scientific assessment of Gulf War health issues. Mil Med (2002) 0.81
Immunization myths and realities: responding to arguments against immunization. J Paediatr Child Health (2003) 0.80
Healthcare workers' knowledge and attitudes about pertussis and pertussis vaccination. Infect Control Hosp Epidemiol (2007) 0.79
The birth and death of microRNA genes in Drosophila. Nat Genet (2008) 3.22
Racial disparities in exposure, susceptibility, and access to health care in the US H1N1 influenza pandemic. Am J Public Health (2010) 1.62
Public willingness to take a vaccine or drug under Emergency Use Authorization during the 2009 H1N1 pandemic. Biosecur Bioterror (2009) 1.53
It's a long, long walk: accessibility to hospitals, maternity and integrated health centers in Niger. Int J Health Geogr (2012) 1.40
Adaptive evolution of newly emerged micro-RNA genes in Drosophila. Mol Biol Evol (2008) 1.31
Postal workers' perspectives on communication during the anthrax attack. Biosecur Bioterror (2005) 1.22
Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res (2010) 1.09
Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia. Drug Alcohol Depend (2011) 1.04
Adverse interactions between micro-RNAs and target genes from different species. Proc Natl Acad Sci U S A (2010) 0.97
The vagaries of public support for government actions in case of a pandemic. Health Aff (Millwood) (2010) 0.93
Health inequalities and infectious disease epidemics: a challenge for global health security. Biosecur Bioterror (2014) 0.84
Combined analysis of allograft inflammatory factor-1, interleukin-18, and Toll-like receptor expression and association with allograft rejection and coronary vasculopathy. Am Surg (2010) 0.77